Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2009
03/25/2009CN101394852A Heterocyclic aspartyl protease inhibitors, preparation and use thereof
03/25/2009CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
03/24/2009US7507822 Cyclizing, halogenating by reacting in presence of catalytic amount of metal halide and dehydrating agent
03/24/2009US7507814 Process for preparation of imipenem
03/24/2009US7507743 Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivatives
03/24/2009US7507740 Fused heterocyclic compound
03/24/2009US7507739 Against tumors expressing multiple drug resistance by promoting microtubule polymerization; deesterification of a phenyldiester with 3-amino-1,2,4-triazole, halogenation with a phosphorusoxyhalide, amination with a perfluoroalkylamine in the presence of a strong base and aprotic solvent
03/24/2009US7507734 Pyridazinone derivatives
03/24/2009US7507730 Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators
03/24/2009US7507726 Antibiotic; bactericides
03/24/2009US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor
03/24/2009US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention
03/24/2009US7507397 Delivery of muscle relaxants through an inhalation route
03/24/2009CA2422380C Pyrazole compounds useful as protein kinase inhibitors
03/24/2009CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases
03/19/2009WO2009036132A1 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
03/19/2009WO2009035568A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
03/19/2009WO2009034386A1 Derivatives of adenine and 8-aza-adenine and uses thereof-796
03/19/2009WO2009034169A1 Processes for the preparation of the alpha crystal polymorph of metal phthalocyanines
03/19/2009WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors
03/19/2009WO2009013299A3 Novel bradykinin b1 antagonists
03/19/2009WO2008153793A3 Gamma secretase modulators
03/19/2009US20090076269 administering purinones such as 6-pentyl-8-(trifluoromethyl)-6,9-dihydro-5H-[1,2,4]triazolo[3,4-i]purin-5-one, having G protein– coupled receptor agonistic acitvity, for the treatment of insulin resistance, diabetes, or metabolic syndrome
03/19/2009US20090076200 Letter with continuation application
03/19/2009US20090076061 Muscarinic acetycholine receptor antagonists
03/19/2009US20090076049 Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1
03/19/2009US20090076037 Bicyclic pyrimidine kinase inhibitors
03/19/2009US20090076035 Deuterium-enriched paliperidone
03/19/2009US20090076034 Deuterium-enriched bms-690514
03/19/2009US20090075983 Novel Diazabicycloalkane Derivatives and Their Medical Use
03/19/2009US20090075978 Substituted propiolic acid amides and their use for producing drugs
03/19/2009US20090075969 Deuterium-enriched doripenem
03/19/2009US20090075309 Bisdeoxycoelenterazine derivatives, methods of use, and BRET2 systems
03/19/2009US20090075188 Azo compound, curable composition, color filter, and method of producing the same
03/19/2009US20090074825 Colorants based n-halamines compositions and method of making and using
03/19/2009US20090074717 Anti-viral compounds, compositions, and methods of use
03/19/2009US20090072191 Nor-Seco-Bis-Nor-Seco, Tris-Nor-Seco, and Higher Nor-Seco-Cucurbit[n]Uril Compounds
03/19/2009CA2697682A1 Annelated pyridazines for the treatment of tumors driven by inapropriate hedgehog signalling
03/19/2009CA2691782A1 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
03/18/2009EP2036954A2 Azo compound, curable composition, color filter, and method of producing the same
03/18/2009EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
03/18/2009EP2036908A2 Efficient synthesis of pyropheophorbide a derivates
03/18/2009EP2036561A1 Agent for overcoming resistance to anti-cancer agent
03/18/2009EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES
03/18/2009EP2035428A1 Diketopyrrolopyrrole polymers as organic semiconductors
03/18/2009EP2035427A2 Pyrazolo[1,5-a]pyrimidine compounds as cb1 receptor antagonist
03/18/2009EP2035426A1 Pyrazolopyrimidones
03/18/2009EP2035425A1 Amino- imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia.
03/18/2009EP2035424A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia.
03/18/2009EP2035423A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
03/18/2009EP2035422A1 Pteridine derivatives and their use as cathespin inhibitors
03/18/2009EP2035421A1 2-ARYLPYRAZOLO[L,5-alpha]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA)
03/18/2009EP2035396A2 Triazole compounds that modulate hsp90 activity
03/18/2009EP2035379A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/18/2009EP1625131B1 Process and apparatus for preparing metal or nonmetal phthalocyanine
03/18/2009EP1575960B1 1,4-diazabicyclo 3.2.2 nonanecarboxamide derivatives, preparation and therapeutic use thereof
03/18/2009EP1569936B1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
03/18/2009EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase
03/18/2009EP1389096B1 Delivery of opioids through an inhalation route
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009CN101389632A Spiroketals
03/18/2009CN101389631A Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (PDT)
03/18/2009CN101389630A Protein kinase inhibitors
03/18/2009CN101389627A Antibacterial pyrrolopyridines, pyrrolopyrimidines and pyrroloazepines-154
03/18/2009CN101389626A Fused ring heterocycle kinase modulators
03/18/2009CN101386622A Method for preparing sodium copper chlorophyllin in red-purple pitaya sterm
03/18/2009CN100469779C Inhibitors of interleukin-1beta converting enzyme
03/18/2009CN100469778C Novel fused imidazole derivative
03/17/2009US7504521 Methods for the preparation of pyrrolotriazine compounds
03/17/2009US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent
03/17/2009US7504504 Methods of preparing aripiprazole crystalline forms
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists
03/17/2009US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents
03/17/2009US7504405 Mitotic kinesin inhibitors
03/17/2009US7504404 Compounds as metabotropic glutamate receptor antagonists
03/17/2009US7504403 Substituted heterocyclic compounds and methods of use
03/17/2009US7504399 Piperazine enamines as antiviral agents
03/17/2009US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation
03/17/2009US7504393 Benzylamine analogues
03/17/2009US7504162 Heat resistance; forming film
03/17/2009CA2359116C Substituted porphyrins
03/12/2009WO2009032754A2 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease
03/12/2009WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors
03/12/2009WO2009031406A1 Tetraazaporphyrin mixture, optical filter made by using the same, and displays
03/12/2009WO2009030871A1 Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
03/12/2009WO2009030649A2 Method for producing teda derivatives
03/12/2009WO2009030095A1 Process for preparing vardenafil and its intermediates
03/12/2009WO2009006319A3 Ammosamides as anticancer agents
03/12/2009WO2008125945A3 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c
03/12/2009WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors
03/12/2009WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity
03/12/2009US20090069558 Oxidatively cyclized tetrahydrobilene
03/12/2009US20090069355 Bicyclic pyrazolone cytokine inhibitors
03/12/2009US20090069349 Deuterium-enriched pemetrexed
03/12/2009US20090069315 Use of Pyrazolo(1,5A)Pyrimidin-7-YL Amine Derivatives in the Treatment of Neurological Disorders
03/12/2009US20090069306 Process for producing highly pure midazolam and salts thereof
03/12/2009US20090069298 Pyrazolo[1,5-A]Pyrimidine Compounds